Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook

血脂异常 医学 内科学 剩余风险 胆固醇 风险因素 代谢综合征 脂蛋白 内分泌学 糖尿病 甘油三酯 肥胖
作者
Vikrama Raja,Carlos Aguíar,Nasreen Al-Sayed,Yogeyaa S. Chibber,Hussein ElBadawi,М. В. Ежов,Michel P. Hermans,Ramesh C. Pandey,Kausik K. Ray,Lâle Tokgözoğlu,Alberto Zambon,Jean‐Pascal Berrou,Michel Farnier
出处
期刊:Atherosclerosis [Elsevier BV]
卷期号:383: 117312-117312 被引量:121
标识
DOI:10.1016/j.atherosclerosis.2023.117312
摘要

Dyslipidemia refers to unhealthy changes in blood lipid composition and is a risk factor for atherosclerotic cardiovascular diseases (ASCVD). Usually, low-density lipoprotein-cholesterol (LDL-C) is the primary goal for dyslipidemia management. However, non-high-density lipoprotein cholesterol (non-HDL-C) has gained attention as an alternative, reliable goal. It encompasses all plasma lipoproteins like LDL, triglyceride-rich lipoproteins (TRL), TRL-remnants, and lipoprotein a [Lp(a)] except high-density lipoproteins (HDL). In addition to LDL-C, several other constituents of non-HDL-C have been reported to be atherogenic, aiding the pathophysiology of atherosclerosis. They are acknowledged as contributors to residual ASCVD risk that exists in patients on statin therapy with controlled LDL-C levels. Therefore, non-HDL-C is now considered an independent risk factor or predictor for CVD. The popularity of non-HDL-C is attributed to its ease of estimation and non-dependency on fasting status. It is also better at predicting ASCVD risk in patients on statin therapy, and/or in those with obesity, diabetes, and metabolic disorders. In addition, large follow-up studies have reported that individuals with higher baseline non-HDL-C at a younger age (<45 years) were more prone to adverse CVD events at an older age, suggesting a predictive ability of non-HDL-C over the long term. Consequently, non-HDL-C is recommended as a secondary goal for dyslipidemia management by most international guidelines. Intriguingly, geographical patterns in recent epidemiological studies showed remarkably high non-HDL-C attributable mortality in high-risk countries. This review highlights the independent role of non-HDL-C in ASCVD pathogenesis and prognosis. In addition, the need for a country-specific approach to dyslipidemia management at the community/population level is discussed. Overall, non-HDL-C can become a co-primary or primary goal in dyslipidemia management.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
I2564完成签到,获得积分10
刚刚
Ethan完成签到 ,获得积分10
刚刚
刚刚
fancy完成签到,获得积分10
1秒前
xiongyh10完成签到,获得积分0
5秒前
123完成签到,获得积分10
5秒前
方方完成签到,获得积分10
6秒前
6秒前
7秒前
乐乐应助机智苗采纳,获得10
7秒前
8秒前
华仔应助lehua采纳,获得10
8秒前
华仔应助雇凶暗杀蛋饺采纳,获得10
10秒前
zyy0226发布了新的文献求助10
10秒前
11秒前
12秒前
13秒前
小蘑菇应助polystyrene采纳,获得10
14秒前
ALAI发布了新的文献求助10
14秒前
15秒前
杨硕发布了新的文献求助10
16秒前
Dr.coco完成签到,获得积分10
16秒前
510完成签到 ,获得积分10
18秒前
fifteen应助科研通管家采纳,获得10
19秒前
你笨发布了新的文献求助10
19秒前
传奇3应助科研通管家采纳,获得10
19秒前
田様应助科研通管家采纳,获得10
19秒前
上官若男应助科研通管家采纳,获得10
19秒前
19秒前
CipherSage应助科研通管家采纳,获得20
19秒前
bkagyin应助科研通管家采纳,获得10
19秒前
19秒前
传奇3应助科研通管家采纳,获得10
19秒前
19秒前
19秒前
19秒前
英姑应助科研通管家采纳,获得30
20秒前
20秒前
李爱国应助科研通管家采纳,获得10
20秒前
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Les Mantodea de Guyane Insecta, Polyneoptera 2000
Emmy Noether's Wonderful Theorem 1200
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
基于非线性光纤环形镜的全保偏锁模激光器研究-上海科技大学 800
Signals, Systems, and Signal Processing 610
Wade & Forsyth's Administrative Law 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6410266
求助须知:如何正确求助?哪些是违规求助? 8229581
关于积分的说明 17461748
捐赠科研通 5463363
什么是DOI,文献DOI怎么找? 2886728
邀请新用户注册赠送积分活动 1863153
关于科研通互助平台的介绍 1702351